1
Clinical Trials associated with CAR T cell therapy(Shanghai RNACure Biopharma Co., Ltd.) / SuspendedEarly Phase 1IIT Single-center, open, nonrandomized, single-arm clinical trial of bridging allogeneic hematopoietic stem cell transplantation after CAR T cell remission in refractory/relapsed acute myeloid leukemia
Start Date29 Apr 2022 |
Sponsor / Collaborator- |
100 Clinical Results associated with CAR T cell therapy(Shanghai RNACure Biopharma Co., Ltd.)
100 Translational Medicine associated with CAR T cell therapy(Shanghai RNACure Biopharma Co., Ltd.)
100 Patents (Medical) associated with CAR T cell therapy(Shanghai RNACure Biopharma Co., Ltd.)
100 Deals associated with CAR T cell therapy(Shanghai RNACure Biopharma Co., Ltd.)